These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10590326)

  • 1. DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL).
    Lodmell DL; Ray NB; Ulrich JT; Ewalt LC
    Vaccine; 2000 Jan; 18(11-12):1059-66. PubMed ID: 10590326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-time gene gun or intramuscular rabies DNA vaccination of non-human primates: comparison of neutralizing antibody responses and protection against rabies virus 1 year after vaccination.
    Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
    Vaccine; 2001 Dec; 20(5-6):838-44. PubMed ID: 11738747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rabies DNA vaccination of non-human primates: post-exposure studies using gene gun methodology that accelerates induction of neutralizing antibody and enhances neutralizing antibody titers.
    Lodmell DL; Parnell MJ; Bailey JR; Ewalt LC; Hanlon CA
    Vaccine; 2002 May; 20(17-18):2221-8. PubMed ID: 12009276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1.
    Sasaki S; Tsuji T; Hamajima K; Fukushima J; Ishii N; Kaneko T; Xin KQ; Mohri H; Aoki I; Okubo T; Nishioka K; Okuda K
    Infect Immun; 1997 Sep; 65(9):3520-8. PubMed ID: 9284115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine rabies DNA vaccination: a single-dose intradermal injection into ear pinnae elicits elevated and persistent levels of neutralizing antibody.
    Lodmell DL; Parnell MJ; Weyhrich JT; Ewalt LC
    Vaccine; 2003 Sep; 21(25-26):3998-4002. PubMed ID: 12922136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanogram quantities of plasmid DNA encoding the rabies virus glycoprotein protect mice against lethal rabies virus infection.
    Ray NB; Ewalt LC; Lodmell DL
    Vaccine; 1997 Jun; 15(8):892-5. PubMed ID: 9234541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant vaccine.
    Sasaki S; Hamajima K; Fukushima J; Ihata A; Ishii N; Gorai I; Hirahara F; Mohri H; Okuda K
    Infect Immun; 1998 Feb; 66(2):823-6. PubMed ID: 9453648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response.
    Ito K; Ito K; Shinohara N; Kato S
    Mol Immunol; 2003 May; 39(14):847-54. PubMed ID: 12686500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabies DNA vaccine encoding lysosome-targeted glycoprotein supplemented with Emulsigen-D confers complete protection in preexposure and postexposure studies in BALB/c mice.
    Kaur M; Saxena A; Rai A; Bhatnagar R
    FASEB J; 2010 Jan; 24(1):173-83. PubMed ID: 19741168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
    Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
    Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination with toxofilin DNA in combination with an alum-monophosphoryl lipid A mixed adjuvant induces significant protective immunity against Toxoplasma gondii.
    Song P; He S; Zhou A; Lv G; Guo J; Zhou J; Han Y; Zhou H; Hao Z; Cong H
    BMC Infect Dis; 2017 Jan; 17(1):19. PubMed ID: 28056837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with liposomal leishmanial antigens adjuvanted with monophosphoryl lipid-trehalose dicorynomycolate (MPL-TDM) confers long-term protection against visceral leishmaniasis through a human administrable route.
    Ravindran R; Maji M; Ali N
    Mol Pharm; 2012 Jan; 9(1):59-70. PubMed ID: 22133194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine.
    Gableh F; Saeidi M; Hemati S; Hamdi K; Soleimanjahi H; Gorji A; Ghaemi A
    J Biomed Sci; 2016 Jan; 23():16. PubMed ID: 26811064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-time intradermal DNA vaccination in ear pinnae one year prior to infection protects dogs against rabies virus.
    Lodmell DL; Ewalt LC; Parnell MJ; Rupprecht CE; Hanlon CA
    Vaccine; 2006 Jan; 24(4):412-6. PubMed ID: 16153757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines.
    Wheeler AW; Marshall JS; Ulrich JT
    Int Arch Allergy Immunol; 2001 Oct; 126(2):135-9. PubMed ID: 11729351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant activity of PCP-II, a polysaccharide from Poria cocos, on a whole killed rabies vaccine.
    Zhang W; Cheng N; Wang Y; Zheng X; Zhao Y; Wang H; Wang C; Han Q; Gao Y; Shan J; Yang S; Xia X
    Virus Res; 2019 Sep; 270():197638. PubMed ID: 31173772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection.
    Lodmell DL; Ray NB; Ewalt LC
    Vaccine; 1998; 16(2-3):115-8. PubMed ID: 9607018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of C3d-P28 adjuvant to a rabies DNA vaccine encoding the G5 linear epitope enhances the humoral immune response and confers protection.
    Galvez-Romero G; Salas-Rojas M; Pompa-Mera EN; Chávez-Rueda K; Aguilar-Setién Á
    Vaccine; 2018 Jan; 36(2):292-298. PubMed ID: 29191739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type-1 and hepatitis B virus.
    Fomsgaard A; Nielsen HV; Nielsen C; Johansson K; Machuca R; Bruun L; Hansen J; Buus S
    APMIS; 1998 Jun; 106(6):636-46. PubMed ID: 9725796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.